This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2016 Jan;43(1):163.

doi: 10.1111/apt.13421.

Editorial: screening for NAFLD - a promising strategy to mitigate future burden of liver disease

R Sinha¹, K A Lockman²

Affiliations

Affiliations

¹ Department of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, UK.
² Department of Acute Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK. ann.lockman@nhs.net.

PMID: 26638929
DOI: 10.1111/apt.13421

Editorial

Editorial: screening for NAFLD - a promising strategy to mitigate future burden of liver disease

R Sinha et al. Aliment Pharmacol Ther. 2016 Jan.

. 2016 Jan;43(1):163.

doi: 10.1111/apt.13421.

Authors

R Sinha¹, K A Lockman²

Affiliations

¹ Department of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, UK.
² Department of Acute Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK. ann.lockman@nhs.net.

PMID: 26638929
DOI: 10.1111/apt.13421

No abstract available

PubMed Disclaimer

Comment on

Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.
Doycheva I, Cui J, Nguyen P, Costa EA, Hooker J, Hofflich H, Bettencourt R, Brouha S, Sirlin CB, Loomba R. Doycheva I, et al. Aliment Pharmacol Ther. 2016 Jan;43(1):83-95. doi: 10.1111/apt.13405. Epub 2015 Sep 15. Aliment Pharmacol Ther. 2016. PMID: 26369383 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information